CoChat
Sign Up
Cited by 303Blood Pressure and Hypertension StudiesHealth Systems, Economic Evaluations, Quality of LifeGlobal Health Care Issues

The DOI matches its Crossref record; 9 of the 10 references it cites were found in a registry or an index.

The global cost of nonoptimal blood pressure

Gaziano, Thomas A, Bitton, Asaf, Anand, Shuchi, Weinstein, Milton C·2009·Journal of Hypertension
DOI 10.1097/hjh.0b013e32832a9ba3
Open this paper in CoChat — free account

Abstract

OBJECTIVE: Suboptimal blood pressure including established nonoptimal blood pressure has been shown to have significant economic consequences in developed countries. However, no exhaustive study has been done to evaluate its potential costs, globally. We, therefore, set out to estimate the global economic cost of nonoptimal blood pressure. METHODS: Estimates for healthcare costs attributed to suboptimal blood pressure for those over the age of 30 were made for all the World Bank regions. Annual and 10-year estimates using Markov models were made for the cost of treating nonoptimal blood pressure and its main sequelae: stroke and myocardial infarction. RESULTS: Suboptimal blood pressure cost US$370,000,000,000 globally in 2001. This represents about 10% of the world's overall healthcare expenditures. In the Eastern Europe and Central Asia region, high blood pressure consumed 25% of all health expenditures. Over a 10-year period, elevated blood pressure may cost nearly $1,000,000,000,000 globally in health spending, if current blood pressure levels persist. Indirect costs could be as high as $3,600,000,000,000 annually. CONCLUSION: Suboptimal blood pressure is responsible for a large and an increasing economic and health burden in developing countries. Although the majority of the current absolute expenditure occurs in the high-income countries, an ever-increasing proportion of the cost is going to be carried by developing countries.

Overview

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e32832a9ba3

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 10 references

Research works printed but not linked: 1

  1. Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page

Cited by

Sorted by citations

Items 201–300 of 300

Related

See all

Metadata

Authors
Gaziano, T. A., Bitton, A., Anand, S., & Weinstein, M. C.
Affiliations
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
Corresponding author
Gaziano, Thomas A
ORCID
Venue
Journal of Hypertension
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2009-07
Volume
27
Issue
7
Pages
1472-1477
ISSN
0263-6352 (ISSN-L)
DOI
10.1097/hjh.0b013e32832a9ba3
OpenAlex
W1986783669
Cited by
303
References
10
Citations by year
2026: 12 · 2025: 17 · 2024: 15 · 2023: 19 · 2022: 26 · 2021: 20 · 2020: 20 · 2019: 13 · 2018: 17 · 2017: 14 · 2016: 26 · 2015: 22 · 2014: 14 · 2013: 13 · 2012: 18
FWCI
11.55
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Funders
International Society of Hypertension
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Global Health Care Issues
Keywords
hypertension, economic burden of disease, health care costs, stroke, myocardial infarction, indirect costs, developing countries
MeSH terms
Developing Countries, Humans, Hypertension, Markov Chains, Global Health, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review